O-T

David Palma MD. PhD. FRCPC.

Professor, Departments of Oncology, Medical Biophysics, and Otolaryngology, Schulich School of Medicine & Dentistry, Western University. Radiation Oncologist, Verspeeten Family Cancer Centre, London Health Sciences Centre. Clinician-Scientist, London Health Sciences Research Institute. Clinician-Scientist II, Ontario Institute for Cancer Research. Founder and Chair, Canadian Pulmonary Radiotherapy Investigators (CAPRI).

Research Interests / Specializations: Dr. Palma's research focuses on translational imaging science, including evaluating new imaging and radiotherapy technologies in the pre-clinical and clinical setting.

Brian L. Pagenkopf PhD.

Professor, Department of Chemistry, Organic Teaching Division, Western University.

Research Interests / Specializations: Organic Synthesis

Armen Parsyan MD, PhD, DSc, MPH, FRCSC.

Assistant Professor, Departments of Surgery, and Oncology, Schulich School of Medicine and Dentistry, Western University. General Surgeon and Breast Surgical Oncologist, London Health Sciences Centre. Clinician-Scientist, London Health Sciences Research Institute. Scientist, Cancer Laboratory Research Program.

Research Interests / Specializations: Translational Breast Cancer Research, Patent-Derived in Vitro and In Vivo Models of Breast Cancer, Studies of Novel Multimodality Treatments in Patient-Derived Preclinical Models, Models of Brain Metastases in Breast Cancer, Mechanisms of Breast Cancer Development and Progression, Non-Inferiority Clinical Trials in Surgical Oncology.

Silvia Penuela PhD.

Associate Professor, Departments of Anatomy and Cell Biology, and Oncology Division of Experimental Oncology, Schulich School of Medicine and Dentistry, Western University.

Research Interests / Specializations: Biochemistry and cell biology of pannexins in cancer.

Francisco Perera BSc. ENG. MD. FRCPC.

Associate Professor, Department of Oncology, Schulich School of Medicine & Dentistry, Western University. Radiation Oncologist, Verspeeten Family Cancer Centre.

Research Interests / Specializations: Extensive experience in clinical trials for breast and gastrointestinal malignancies. Key collaborator in the design and completion of clinical trials in breast cancer in collaboration with the Ontario Clinical Oncology Group and the National Cancer Institute of Canada.

Terry Peters PhD. FCCPM.

Fellow, Royal Society of Canada. Professor Emeritus, Departments of Medical Biophysics, and Medical Imaging and Biomedical Engineering, Schulich School of Medicine & Dentistry, Western University. Scientist, Robarts Research Institute.

Research Interests / Specializations: Image-guided surgery; 3-D visualization, non-linear image warping, instrument tracking, multi-modality image registration, brain imaging, cardiac imaging, stereoscopic visualization and virtual reality.

Jim Petrik PhD.

Professor, Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph. Adjunct Professor, Department of Oncology, Schulich School of Medicine & Dentistry, Western University. Adjunct Professor, Department of Obstetrics and Gynecology, Faculty of Medicine, McMaster University. Tier 1 CIHR Canada Research Chair. Fellow, Canadian Academy of Health Sciences.

Research Interests / Specializations: Female reproductive biology and ovarian cancer. Developing novel therapeutics for treatment of late stage ovarian cancer. Focusing on anti angiogenic therapies for inhibiting new growth of blood vessels supplying the tumours.

Christopher Pin, PhD.

Professor, Departments of Physiology and Pharmacology, Oncology and Paediatrics Schulich School of Medicine and Dentistry University of Western. Ontario Distinguished Scientist, Verspeeten Family Cancer Centre, London Health Sciences Centre. Director, Living Biobank for Cancer Research. Scientist, Cancer Research Laboratory Program, London Health Sciences Research Institute.

Research Interests / Specializations: PI, CIHR and NSERC funding on pancreatic cancer; Molecular Biology; Epigenetics; Animal modeling of cancer

Lisa Porter PhD.

Distinguished Professor, Department of Biomedical Sciences, University of Windsor. Executive Director, WE-SPARK Health Institute. Vice-President, Research and Scientific Director, St. Joseph's Health Care London. CIHR UD Advisory Committee. Member, Board of Directors, Research Canada.

Research Interests / Specializations: Molecular/cell biology as it pertains to cancer biology and links to normal development. Focus on cell cycle and cell growth regulation in breast, brain, liver, prostate cancer. Uses mouse and zebrafish models as well as cell lines and patient-derived samples and clinical data.

Nicholas Power MD. FRCSC.

Associate Professor, Department of Urology, and Oncology, Schulich School of Medicine & Dentistry, Western University. Surgical Oncologist, London Health Sciences Centre.

Research Interests / Specializations: Clinical care; Translational research; Prostate, renal, testicular cancer; tumor banking

Frank S. Prato PhD, FCCPM, ABMP, FCOMP, FURSI, FCAHS

Professor, Departments of Medical Biophysics, and Medical Imaging, Schulich School of Medicine & Dentistry, Western University. Assistant Scientific Direcctor and Imaging Program Leader, Lawson Research Institute at St. Joseph's Health Care London. Scientist, Robarts Research Institute. Founder, Canadian Organization of Medical Physicists (COMP). Former President, Canadian College of Medical Physicists. Winner, 2024 COMP Gold Medal.

Research Interests / Specializations: Driving force behind Canada's first PET/MR scanner.

Douglas Quan MD. FRCSC.

Associate Professor, Departments of Surgery and Oncology, Schulich School of Medicine & Dentistry, Western University. Associate Scientist, Lawson Research Institute at St. Joseph's Health Care London.

Research Interests / Specializations: Liver disorders, HPB Surgery, Transplantation

Jacques Raphael MD. FRCPC.

Assistant Professor, Schulich School of Medicine & Dentistry, Western University. Adjunct Scientist, ICES Western. Associate Scientist, London Health Sciences Research Institute.

Research Interests / Specializations: Clinical - Breast and Lung Cancer. Research - Early phase drug trials and biomarker studies. Systematic reviews/meta-analyses

Michael Rieder MD. PhD.

Professor, Department of Paediatrics, Physiology & Pharmacology and Medicine, Schulich School of Medicine & Dentristy, Western University. Head, Division of Pediatric Clinical Pharmacology. Scientist, Robarts Research Institute. Member, Drug Therapy Committee of the Canadian Paediatric Scociety. Member of the Executive of the Canadian Society of Pharmacology and Therapeutics. Consultant to Health Canada, the NIH, the MRC and the College of Academies.

Research Interests / Specializations: Research focuses on drug safety and adverse drug reactions as well as optimal therapeutics in children. Studies generic variations and their impact on drug efficacy and safety and the mechanims of drug hypersensitivity.

George Rodrigues MD. PhD. FRCPC, FASTRO.

Professor, Departments of Epidemiology & Biostatistics, and Oncology, Schulich School of Medicine & Dentistry, Western University. Radiation Oncologist, Verspeeten Family Cancer Centre, London Health Sciences Centre. Clinician Scientist, London Health Sciences Research Institute. President, Canadian Assocation for Radiation Oncologist (CARO).

Research Interests / Specializations: Radiation Oncology; Prostate & GU, Lung Cancers; Brain Metastases, Epidemiology & Biostatistics: Markov modeling; Database analysis, Clinical Trials

John Ronald PhD.

Associate Professor, Departments of Medical Biophysics and Oncology, Schulich School of Medicine & Dentistry, Western University. Scientist, Robarts Research Institute. Associate Scientist, Lawson Research Institute at St. Joseph's Health Care London.

Research Interests / Specializations: Research focusees on pioneering novel molecular and cellular imaging technologies. Specific interest on improving early cancer detection, improved monitoring state-of-the-art gene-based and cell-based therapies for cancer and other disease.

Kathryn Roth MD. RCPSC.

MD. RCPSC. Associate Professor, Departments of Otolaryngology - Head & Neck Surgery and Oncology. Director Undergraduate Medical Education, Schulich School of Medicine & Dentistry, Western University. General Surgeon, St. Joseph's Health Care London.

Research Interests / Specializations: Melanoma, sentinel node biopsy, tumour molecular expression in advanced cutaneous carcinoma, thyroid cancer prognostication, medical education simulation and skill acquisition.

Bekim Sadikovic PhD. DABMG (Cyto;Mol), FACMG.

Program and Head, Molecular Diagnositcs Program, Department of Pathology and Laboratory Medicine, Schulich School of Medicine & Dentistry, Western University. LHSC Research Chair in Clinical Genomics and Epigenomics. Clinical and Scientific Director, Verspeeten Clinical Genome Centre. Associate Scientist, London Health Sciences Research Institute. Chief Scientific Officer, EpiSign Inc.

Research Interests / Specializations: Division Head, Molecular Diagnostics Division, Pathology and Laboratory Medicine; Professor, Pathology and Laboratory Medicine; Molecular Diagnostics, Genomics, Epigenomics, Hereditary and Somatic Oncology, Computational Biology, Machine Learning, Big Data

Caroline Schild-Poulter PhD.

Professor, Departments of Biochemistry, and Oncology, Schulich School of Medicine & Dentistry, Western University. Scientist, Molecular Medicine Research Group, Robarts Research Institute.

Research Interests / Specializations: Mechanisms of cancer development; Cellular response to DNA damage

Timothy Scholl PhD.

Associate Professor, Department of Medical Biophysics, Schulich School of Medicine & Dentistry, Western University. Scientist, Imaging Research Laboratories, Robarts Research Institute. Investigator, Ontario Institute for Cancer Research.

Research Interests / Specializations: Research focus on measuring cancer metabolism with magnetic resonance imaging. Specific interests in characterizing human prostate cancer with sodium MRI and development of hyperpolarized 13C magnetic resonance spectroscopic imaging for assessing therapeutic response in pre-clinical models of glioma.

Trevor Shepherd PhD.

Associate Professor, Departments of Obstetrics & Gynecology, Oncology, and Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, Western University. Translational Oncology Scientist, Mary and John Knight Translational Ovarian Cancer Research Unit, Cancer Research Laboratory Program, London Health Sciences Research Institute.

Research Interests / Specializations: Ovarian cancer; metastasis; 3D spheroid; patient-derived samples; cell signalling; tumour dormancy; therapeutics testing

Brian Shilton PhD.

Professor, Department of Biochemistry. Director of Macromolecular Crystallography Facility. Schulich School of Medicine & Dentistry, Western University.

Research Interests / Specializations: Molecular structure and enzyme mechanism; molecular dynamics; nicotinamide function and metabolism; drug interactions; quinone reductases 1 and 2; Pin1 peptidyl prolyl isomerase; p53 tumor suppressor; 20S proteosome

Parisa Shooshtari PhD.

Assistant Professor, Department of Pathology and Laboratory Medicine and Computer Science, Schulich School of Medicine & Dentistry, Western University. Investigator, Ontario Institute for Cancer Research (OICR). Scientist, Child Health Research Institute (CHRI).

Research Interests / Specializations: Bioinformatics, Computational Biology, Multi-Omics, Data Integration, Machine Learning, Single-cell Sequencing, Epigenetic.

Krishna Singh PhD.

Associate Professor, Departments of Anatomy and Cell Biology, and Medical Biophysics, Schulich School of Medicine & Dentistry, Western University.

Research Interests / Specializations: Autophagy, DNA damage and repair, endothelial-to-mesenchymal transition, cardiovascular diseases and organ fibrosis.

Peter Stathopulos PhD.

Associate Professor, Department of Physiology and Pharmacology, Western University.

Research Interests / Specializations: Structural biology; calcium signaling; molecular pharmacology; protein folding; ion channels; SOCE; mitochondrial Ca2+;cancer; heart disease; immunodeficiency.

Michael Strong

MD, FRCP(C), FANN, FCAHS, Professor of Neurology, Western University. President, Canadian Institute of Health Research.

Research Interests / Specializations: Focuses on understanding the cellular biology of ALS and has led to an understanding of the mechanisms by which intracellular deposits of protein are formed, and how these aggregates contribute to the understanding of neurophychological deficits in ALS, both clinically and at the cellular level.

Jonathan D. Thiessen PhD.

Associate Professor, Departments of Medical Biophysics and Medical Imaging, Schulich School of Medicine & Dentistry. PET/MRI Scientific Director, Lawson Research Health Institute at St. Joseph's Health Care London. Associate Member, The Brain & Mind Institute, Western University.

Research Interests / Specializations: PET/MRI of prostate cancer, glioma, cardiac disease, and neurodegenerative disorders.

Alexander Timoshenko PhD. DSc.

Associate Professor, Departments of Biology, and Oncology, Schulich School of Medicine & Dentistry, Western University.

Research Interests / Specializations: Cancer Cell Biology; Glycobiology; Cell Biology and Biomedical Application of Galectins; Tissue-Specific Galectins and Cell Differentiation

Elena Tsvetkova MD. MEd. FRCPC.

Assistant Professor, Department of Oncology, Schulich School of Medicine & Dentistry, Western University. Medical Oncologist, Verspeeten Family Cancer Centre, London Health Sciences Centre.

Research Interests / Specializations: Clinical: GI, NET, Breast, GIST. Research: Pancreatic Cancer and Pancreatic Neuroendocrine Tumours.

Eva Turley PhD.

Professor, Departments of Biochemistry, Surgery, and Oncology, Schulich School of Medicine & Dentistry, Western University. Distinguished Oncology Scientist, Cancer Research Laboratory Program, London Health Sciences Research Institute.

Research Interests / Specializations: Breast cancer; Cellular and molecular mechanisms of metastasis; 3D cell culture models; Translational research; Novel therapeutics. Fibrosis and inflammation in tumour microenvironments.